U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550088) titled 'BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases' on April 15.
Brief Summary: The goal of this clinical trial is to learn whether the combination of balstilimab, botensilimab, and agenT-797 is safe and effective in treating adults with previously treated metastatic colorectal cancer that is microsatellite stable (pMMR) and has spread to the liver.
The main questions it aims to answer are:
* What proportion of participants experience tumor shrinkage (objective response rate) based on imaging assessments?
* What side effects occur with this combination treatment, including immune-related and cytokine-related reactions?
All par...